Monocyte chemotactic protein-1 (CCL2, alternative: MCP-1) plasma levels were significantly higher in progressors with CKD (p = 0.021) and CVD (p = 0.013) compared to NPs (Supplementary Figures 4F, G). Here, CCL2 is linked to chronic kidney disease.